IHS vs VEON
IHS and VEON side by side, both in telephone communications. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IHS and VEON compare
VEON grew revenue faster over the last twelve months (9.9% versus 6.8% for IHS).
IHS scores higher on the StockData Score (6 against 2 for VEON), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IHS | VEON |
|---|---|---|
| Size and price | ||
| Share price | $8.42 | $79.17 |
| Change, 1 year | 22.4% | 67.3% |
| Change, 5 years | −43.9% | 73.0% |
| Beta (5Y) | 1.13 | 1.21 |
| Employees | 2,762 | 19K |
| StockData Score | ||
| Total score | 6 (better) | 2 |
| Valuation score | 0 | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 3 (better) | 0 |
| Health score | 2 (better) | 0 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 6.8% | 9.9% (better) |
| Revenue growth, 5Y average | 2.4% | 4.8% (better) |
| Net income growth (TTM) | 28.0% | – |
| EPS growth (TTM) | – | 30.4% |
| Profitability | ||
| Gross margin | 55.8% | – |
| Operating margin | 45.5% (better) | 32.7% |
| Net margin | 9.1% | – |
| FCF margin | 43.5% | – |
| Return on invested capital | 28.0% | – |
| Financial health | ||
| Net debt / EBITDA | 2.88 | – |
| Interest coverage | 2.1× | 2.7× (better) |
| Current ratio | 1.93 | – |
| Piotroski F-score | 8 | – |
| Dividends and buybacks | ||
| Years of dividend growth | – | 0 |
| Ownership | ||
| Held by institutions | 47.6% | 0.85% |
| Held by insiders | 6.6% | 45.7% |
| Insider net buying, 12 months | −$2.8M | $1.1M (better) |
| Short interest, % of float | 0.87% | – |
Go deeper
- IHS stock overview
- IHS income statement
- IHS valuation and score
- VEON stock overview
- VEON income statement
- VEON valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.